Home » Topics » Disease categories and therapies » Infection

Infection
RSS

ViroPharma announces successful VRI program with pleconaril

July 19, 1999

Clinical trial program for daptomycin updated by Cubist

July 16, 1999

Ramoplanin successfully completes phase II as VRE therapy

July 16, 1999

Proposed market formulation of Ro-64-0796 bioequivalent to other capsule and liquid formulations

July 15, 1999

Salix updates rifaximin clinical development as BID therapy

July 15, 1999

StressGen begins second phase I safety trial of HspE7

July 15, 1999

Abgenix and U.S. Army to cooperate on antibody-based defenses against filoviruses

July 15, 1999

Broad-spectrum antivirals with heterocyclic structure developed at BioChem Pharma

July 14, 1999

WHO develops pyronaridine, an orally active agent for treating chloroquine-resistant malaria

July 13, 1999

Bristol-Myers Squibb extends antiinfective collaboration with Cubist Pharmaceuticals

July 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...